Press Releases

Date	Title	Company
23-Mar-2022	Automated Guided Vehicle Market To Witness Surge in Demand Owing To Rising (use Adoption) : FactMR	MARKITWIRED Latest Market Reports
23-Mar-2022	LifeMine Therapeutics and GSK Enter Drug Discovery and Development Alliance	LifeMine Therapeutics
23-Mar-2022	Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care	Huma
23-Mar-2022	AccuStem Sciences, Inc. Announces DTC Eligibility	AccuStem Sciences, Inc.
23-Mar-2022	atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update	atai Life Sciences
23-Mar-2022	ONK Therapeutics Brings in US Financial Experience with the Appointment of Dr. Allan Reine as Independent Non-Executive Director	ONK Therapeutics
23-Mar-2022	Knee Hyaluronic Acid Injections Market are expected to reach US$ 3.0 Billion by 2031	MARKITWIRED
23-Mar-2022	Active Humidifier Devices Market was valued at US$ 1.2 Bn in 2020 and is expected to surpass US$ 1.1 Bn by 2031	MARKITWIRED
23-Mar-2022	Teleradiology Market is projected to register a CAGR of 15.3% during forecast period 2022-2032	MARKITWIRED
23-Mar-2022	Home Infusion Therapy Devices Market is expected to total US$ 3.8 Billion by the end of 2031	MARKITWIRED
23-Mar-2022	Manometry System Market registered positive growth at 5.4% CAGR, reaching a valuation of US$ 279.6 Million by 2031	MARKITWIRED
23-Mar-2022	Intraosseous Infusion Devices Market is expected to reach US$ 7.9 Billion by 2031	MARKITWIRED
23-Mar-2022	Drugs of Abuse Testing Market sales growing at above 5% CAGR through 2021-2031	MARKITWIRED
23-Mar-2022	Cold Laser Therapy Market is poised to expand at a CAGR of 4.4% between 2021 and 2031	MARKITWIRED
23-Mar-2022	Measurement Technology in Downstream Processing Market is expected to reach US$ 7.2 Billion by 2028	MARKITWIRED
23-Mar-2022	Cardiac Biomarker Diagnostic Test Kits Market is projected to expand at 5.1% CAGR over the forecast period 2022 to 2028	MARKITWIRED
23-Mar-2022	Kayentis launches fully integrated platform for decentralized clinical trials	Andrew Lloyd Associates
23-Mar-2022	Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials	Eckert & Ziegler Strahlen- und Medizintechnik AG
23-Mar-2022	4D pharma announces positive interim results from the Phase I/II study of the combination of MRx0518 and KEYTRUDA(R) (pembrolizumab) for the treatment of renal cell carcinoma	4D pharma
23-Mar-2022	Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent	Vifor Pharma